ATL-003: Prion Disease

Categoría
Drugs National Companies
Tipo de registro
Biotech Sanitaria
Nombre socio
Producto / Servicio
ATL-003: Prion Disease
Tipo
Biodrugs/ Drugs
Area terapéutica
Enfermedades genéticas y raras
Propiedades/Indicación
Prion disease (e.g., Creutzfeldt-Jakob disease) results from the progressive accumulation of an abnormal form of the naturally occurring cellular prion protein leading to subsequent adverse effects on brain function and ultimately death. This project is at the hit identification phase of discovery.
Fase de desarrollo
R&D
Fases desarrolladas en España
R&D